Other Viruses Citation List: July 19 - August 1, 2013
Hepatitis B Virus
1. A New Phenylethanoid Glycoside with Antioxidant and anti-HBV Activity from Tarphochlamys affinis. Zhou, X.L., Q.W. Wen, X. Lin, S.J. Zhang, Y.X. Li, Y.J. Guo, and R.B. Huang. Archives of Pharmacal Research, 2013. [Epub ahead of print]; PMID[23893479].
[PubMed] OV_0719-080113.
2. Inactivation of Hepatitis B Virus Replication in Cultured Cells and in Vivo with Engineered Transcription Activator-like Effector Nucleases. Bloom, K., A. Ely, C. Mussolino, T. Cathomen, and P. Arbuthnot. Molecular Therapy, 2013. [Epub ahead of print]; PMID[23883864].
[PubMed] OV_0719-080113.
3. Inducible Interleukin 32 (IL-32) Exerts Extensive Antiviral Function via Selective Stimulation of Interferon Lambda1 (IFN-Lambda1). Li, Y., J. Xie, X. Xu, L. Liu, Y. Wan, Y. Liu, C. Zhu, and Y. Zhu. The Journal of Biological Chemistry, 2013. 288(29): p. 20927-20941; PMID[23729669].
[PubMed] OV_0719-080113.
Hepatitis C Virus
4. Characterizations of HCV NS5A Replication Complex Inhibitors. O'Boyle Ii, D.R., J.H. Sun, P.T. Nower, J.A. Lemm, R.A. Fridell, C. Wang, J.L. Romine, M. Belema, V.N. Nguyen, D.R. Laurent, M. Serrano-Wu, L.B. Snyder, N.A. Meanwell, D.R. Langley, and M. Gao. Virology, 2013. [Epub ahead of print]; PMID[23896639].
[PubMed] OV_0719-080113.
5. Inhibition of Hepatitis C Virus Infection by DNA Aptamer Against Envelope Protein. Yang, D., X. Meng, Q. Yu, L. Xu, Y. Long, B. Liu, X. fang, and H. Zhu. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]; PMID[23877701].
[PubMed] OV_0719-080113.
6. A Hepatitis C Virus NS4B Inhibitor Suppresses Viral Genome Replication by Disrupting NS4B'S Dimerization/Multimerization as Well as Its Interaction with NS5A. Choi, M., S. Lee, T. Choi, and C. Lee. Virus Genes, 2013. [Epub ahead of print]; PMID[23868571].
[PubMed] OV_0719-080113.
7. HCV NS5A Replication Complex Inhibitors. Part 5: Discovery of Potent and Pan-genotypic Glycinamide Cap Derivatives. Belema, M., V.N. Nguyen, D.R. St Laurent, O.D. Lopez, Y. Qiu, A.C. Good, P.T. Nower, L. Valera, D.R. O'Boyle, 2nd, J.H. Sun, M. Liu, R.A. Fridell, J.A. Lemm, M. Gao, J.O. Knipe, N.A. Meanwell, and L.B. Snyder. Bioorganic & Medicinal Chemistry Letters, 2013. 23(15): P. 4428-4435; PMID[23803586].
[PubMed] OV_0719-080113.
8. High Potency Improvements to Weak Aryl Uracil HCV Polymerase Inhibitor Leads. Donner, P., J.T. Randolph, P. Huang, R. WagneR, C. Maring, B.H. Lim, L. Colletti, Y. Liu, R. Mondal, J. Beyer, G. Koev, K. Marsh, D. Beno, K. Longenecker, T. Pilot-Matias, W. Kati, A. Molla, and D. Kempf. Bioorganic & Medicinal Chemistry LetterS, 2013. 23(15): P. 4367-4369; PMID[23791079].
[PubMed] OV_0719-080113.
9. Discovery of Novel P2 Substituted 4-Biaryl proline Inhibitors of Hepatitis C Virus NS3 Serine Protease. Bailey, M.D., T. Halmos, and C.T. Lemke. Bioorganic & Medicinal Chemistry Letters, 2013. 23(15): P. 4436-4440; PMID[23773864].
[PubMed] OV_0719-080113.
10. Peptide Backbone Replacement of Hepatitis C Virus NS3 Serine Protease C-terminal Cleavage Product Analogs: Discovery of Potent Succinamide Inhibitors. Bailey, M.D., J. Bordeleau, M. Garneau, M. Leblanc, C.T. Lemke, J. O'Meara, P.W. White, and M. Llinas-Brunet. Bioorganic & Medicinal Chemistry Letters, 2013. 23(15): P. 4447-4452; PMID[23773863].
[PubMed] OV_0719-080113.
Herpes Simplex Virus 1
11. In Vitro Antiviral Activity of Plant Extracts from Asteraceae Medicinal Plants. Jaime, M.F., F. Redko, L.V. Muschietti, R.H. Campos, V.S. Martino, and L.V. Cavallaro. Virology Journal, 2013. 10(1): p. 245; PMID[23890410].
[PubMed] OV_0719-080113.
12. Aldol-type Compounds from Water-soluble Indole-3,4-Diones: Synthesis, Kinetics, and Antiviral Properties. Scala, A., M. Cordaro, A. Mazzaglia, F. Risitano, A. Venuti, M.T. Sciortino, and G. Grassi. Molecular Diversity, 2013. 17(3): p. 479-488; PMID[23640033].
[PubMed] OV_0719-080113.
Herpes Simplex Virus 2
13. A Modified Zinc Acetate Gel, a Potential Nonantiretroviral Microbicide, Is Safe and Effective against Simian-human Immunodeficiency Virus and Herpes Simplex Virus 2 Infection in Vivo. Kenney, J., A. Rodriguez, L. Kizima, S. Seidor, R. Menon, N. Jean-Pierre, P. Pugach, K. Levendosky, N. Derby, A. Gettie, J. Blanchard, M. Piatak, Jr., J.D. Lifson, G. Paglini, T.M. Zydowsky, M. Robbiani, and J.A. Fernandez Romero. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 4001-4009; PMID[23752515].
[PubMed] OV_0719-080113.
Citations from the ISI Web of Knowledge Listings for O.V.
14. Antimicrobial and Antiviral Activity-guided Fractionation from Scutia buxifolia reissek Extracts. Boligon, A.A., T.F. Kubica, D.N. Mario, T.F. de Brum, M. Piana, R. Weiblen, L. Lovato, S.H. Alves, R.C.V. Santos, C.F.D. Alves, and M.L. Athayde. Acta Physiologiae Plantarum, 2013. 35(7): p. 2229-2239; ISI[000320561500019].
[WOS] OV_0719-080113.
15. Effectiveness of Human, Camel, Bovine and Sheep Lactoferrin on the Hepatitis C Virus Cellular Infectivity: Comparison Study. El-Fakharany, E.M., L. Sanchez, H.A. Al-Mehdar, and E.M. Redwan. Virology Journal, 2013. 10; ISI[000320961100001].
[WOS] OV_0719-080113.
16. Development of a Multiplex Phenotypic Cell-based High Throughput Screening Assay to Identify Novel Hepatitis C Virus Antivirals. Kim, H.Y., X. Li, C.T. Jones, C.M. Rice, J.M. Garcia, A. Genovesio, M.A.E. Hansen, and M.P. Windisch. Antiviral Research, 2013. 99(1): p. 6-11; ISI[000320906600002].
[WOS] OV_0719-080113.
17. A Facile Synthesis of (5-Hydroxy-4-oxo-4h-pyran-2-yl)methyl carboxylates and Their Antiviral Activity Against Hepatitis C Virus. Shimo, T., Y. Taketsugu, T. Goto, M. Toyama, K. Yoshimura, and M. Baba. Heterocycles, 2013. 87(6): P. 1355-1364; ISI[000320678000012].
[WOS] OV_0719-080113.